These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3513567)

  • 1. Oral folic acid versus placebo in the treatment of males with the fragile X syndrome.
    Hagerman RJ; Jackson AW; Levitas A; Braden M; McBogg P; Kemper M; McGavran L; Berry R; Matus I; Hagerman PJ
    Am J Med Genet; 1986; 23(1-2):241-62. PubMed ID: 3513567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose folic acid treatment of fragile (X) males.
    Brown WT; Cohen IL; Fisch GS; Wolf-Schein EG; Jenkins VA; Malik MN; Jenkins EC
    Am J Med Genet; 1986; 23(1-2):263-71. PubMed ID: 3513568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid treatment in males and females with fragile-(X)-syndrome.
    Froster-Iskenius U; Bödeker K; Oepen T; Matthes R; Piper U; Schwinger E
    Am J Med Genet; 1986; 23(1-2):273-89. PubMed ID: 3513569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid treatment of fragile X males: a further study.
    Fisch GS; Cohen IL; Gross AC; Jenkins V; Jenkins EC; Brown WT
    Am J Med Genet; 1988; 30(1-2):393-9. PubMed ID: 3052065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled study of folic acid treatment in three fragile X syndrome males.
    Madison LS; Wells TE; Fristo TE; Benesch CG
    J Dev Behav Pediatr; 1986 Aug; 7(4):253-6. PubMed ID: 3528223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of folic acid treatment in the fragile X syndrome.
    Gustavson KH; Dahlbom K; Flood A; Holmgren G; Blomquist HK; Sanner G
    Clin Genet; 1985 May; 27(5):463-7. PubMed ID: 4006270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of behavior change in a fragile-X syndrome male treated with folic acid.
    Wells TE; Madison LS
    Am J Med Genet; 1986; 23(1-2):291-6. PubMed ID: 3953651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid as an adjunct in the treatment of children with the autism fragile-X syndrome (AFRAX).
    Gillberg C; Wahlström J; Johansson R; Törnblom M; Albertsson-Wikland K
    Dev Med Child Neurol; 1986 Oct; 28(5):624-7. PubMed ID: 3536640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid therapy in the fragile X syndrome.
    Brown WT; Jenkins EC; Friedman E; Brooks J; Cohen IL; Duncan C; Hill AL; Malik MN; Morris V; Wolf E
    Am J Med Genet; 1984 Jan; 17(1):289-97. PubMed ID: 6711601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Trial of folic acid treatment in fragile X syndrome].
    Lejeune J; Rethoré MO; de Blois MC; Ravel A
    Ann Genet; 1984; 27(4):230-2. PubMed ID: 6335369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid blinded trial in identical twins with fragile X syndrome.
    Rosenblatt DS; Duschenes EA; Hellstrom FV; Golick MS; Vekemans MJ; Zeesman SF; Andermann E
    Am J Hum Genet; 1985 May; 37(3):543-52. PubMed ID: 3890529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid therapy in the fragile X syndrome.
    Erbe RW
    Am J Med Genet; 1984 Jan; 17(1):299-301. PubMed ID: 6711602
    [No Abstract]   [Full Text] [Related]  

  • 13. Folate treatment of a boy with fragile-X syndrome.
    Webb T; Crawley P; Bundey S
    J Ment Defic Res; 1990 Feb; 34 ( Pt 1)():67-73. PubMed ID: 2325121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled trial of stimulant medication in children with the fragile X syndrome.
    Hagerman RJ; Murphy MA; Wittenberger MD
    Am J Med Genet; 1988; 30(1-2):377-92. PubMed ID: 3052064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary evaluation of the treatment with folic acid in 2 patients with sex-linked mental retardation and macroorchidism].
    Lacassie Y; Curotto B; Alliende MA; De Andraca I; Zavala A
    Rev Med Chil; 1984 May; 112(5):469-73. PubMed ID: 6505437
    [No Abstract]   [Full Text] [Related]  

  • 16. Folic acid for fragile X syndrome.
    Rueda JR; Ballesteros J; Guillen V; Tejada MI; Solà I
    Cochrane Database Syst Rev; 2011 May; (5):CD008476. PubMed ID: 21563169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, placebo-controlled crossover study of folinic acid (Leucovorin for the treatment of fragile X syndrome.
    Strom CM; Brusca RM; Pizzi WJ
    Am J Med Genet; 1992 Nov; 44(5):676-82. PubMed ID: 1481832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragile X syndrome.
    de la Cruz FF
    Am J Ment Defic; 1985 Sep; 90(2):119-23. PubMed ID: 3901755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile-X syndrome: variability of phenotypic expression.
    Bregman JD; Dykens E; Watson M; Ort SI; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 1987 Jul; 26(4):463-71. PubMed ID: 3308830
    [No Abstract]   [Full Text] [Related]  

  • 20. Folic acid metabolism in a patient with fragile X.
    Brøndum Nielsen K; Tommerup N; Friis B; Hjelt K; Hippe E
    Clin Genet; 1983 Sep; 24(3):153-5. PubMed ID: 6627717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.